6 avaliação da doença vascular do enxerto no transplante cardíaco: experiência de um centro brasileiro assessment of cardiac allograft vasculopathy in cardiac transplantation: experience of a brazilian center

7 curva de aprendizado em cirurgia aórtica videolaparoscópica: estudo experimental em porcos laparoscopic aortic surgery learning curve: experimental study in pigs

8 Preeclampsia and cardiovascular disease: interconnected paths that enable detection of the subclinical stages of obstetric and cardiovascular diseases

9 Preeclampsia and cardiovascular disease: interconnected paths that enable detection of the subclinical stages of obstetric and cardiovascular diseases

10 Dilating Vascular Diseases: Pathophysiology and Clinical Aspects

11 Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases.

12 Multimorbidity Analysis According to Sex and Age towards Cardiovascular Diseases of Adults in Northeast China

13 Pattern of Vascular Diseases at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia.

14 Understanding the chinese hui ethnic minority’s information seeking on cardiovascular diseases: A focus group study

15 Aged garlic extract preserves cutaneous microcirculation in patients with increased risk for cardiovascular diseases: A double-blinded placebo-controlled study.

16 Investigations of the impact of polluted natural waters on cardiovascular diseases and development of integrated prevention system

17 Implications of Necroptosis for Cardiovascular Diseases.

18 Clinical significance of Charlson comorbidity index as a prognostic parameter for patients with acute or subacute idiopathic interstitial pneumonias and acute exacerbation of collagen vascular diseases-related interstitial pneumonia.

19 Mortality from cardiovascular diseases in sub-Saharan Africa, 1990-2013: a systematic analysis of data from the Global Burden of Disease Study 2013.

20 THE USE OF NEURAL NETWORKS FOR THE AUTOMATIC ANALYSIS OF ELECTROCARDIOGRAMS IN DIAGNOSIS OF CARDIOVASCULAR DISEASES

21 Stress at intellectual work and cardiovascular diseases in women at non-mobility working age.

22 Community perceptions of dietary and environmental factors as cardiovascular diseases risk determinants.

23 A-kinase anchoring protein 1 (AKAP1) and its role in some cardiovascular diseases.

24 Effects of road traffic noise on the prevalence of cardiovascular diseases: The case of Thessaloniki, Greece

25 Exposure to air pollution and risk of hospitalization for cardiovascular diseases amongst Vietnamese adults: Case-crossover study

26 A study to evaluate herb-drug interaction underlying mechanisms: An investigation of ginsenosides attenuating the effect of warfarin on cardiovascular diseases

27 Pharmaceutical Development and Safety Evaluation of a GMP-Grade Fucoidan for Molecular Diagnosis of Cardiovascular Diseases.

28 The effect of short message system (SMS) reminder on adherence to a healthy diet, medication, and cessation of smoking among adult patients with cardiovascular diseases.

29 [Research progress on the relationship between circular RNA and cardiovascular diseases].

30 Allicin pharmacology: Common molecular mechanisms against neuroinflammation and cardiovascular diseases

31 COVID-19 in patients with cardiovascular diseases

32 Response to the editorial “COVID-19 in patients with cardiovascular diseases”: Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes

33 The Effect of Coronavirus Disease 2019 on Cardiovascular Diseases.

34 study of erythrocyte indices, erythrocyte morphometric indicators, and oxygen-binding properties of hemoglobin hematoporphyrin patients with cardiovascular diseases

35 atherosclerosis biomarkers in female systemic lupus erythematosus patients with and without cardiovascular diseases

36 pparδ activity in cardiovascular diseases: a potential pharmacological target

37 outpatient registry of cardiovascular diseases (recvasa): prospective follow-up data, estimation of risks and outcomes in patients with atrial fibrillation

38 helicobacter pylori and cardiovascular complications: a mechanism based review on role of helicobacter pylori in cardiovascular diseases

39 menopausal hormone treatments and risk of cardiovascular diseases: modern view

40 a study on risk factors of cardiovascular diseases in an urban health center of kolkata

41 mif and cxcl12 in cardiovascular diseases: functional differences and similarities

42 the ace gene insertion/deletion polymorphism and cerebrovascular diseases in uzbek patients with arterial hypertension

43 plaque regression and plaque stabilisation in cardiovascular diseases

44 risk factors of cardiovascular diseases in bushehr port on the basis of the who monica project the persian gulf healthy heart project

45 impact of endothelial microparticles on coagulation, inflammation, and angiogenesis in age-related vascular diseases

46 extraskeletal effects of vitamin d: role in the pathogenesis of cardiovascular diseases

47 endoplasmic reticulum stress-related inflammation and cardiovascular diseases

48 local anesthetics in patients with cardiovascular diseases.

49 regulation of ddah1 as a potential therapeutic target for treating cardiovascular diseases

50 cellular and molecular mechanisms of chronic kidney disease with diabetes mellitus and cardiovascular diseases as its comorbidities

51 polymorphisms in the interleukin-10 gene and chronic periodontitis in patients with atherosclerotic and aortic aneurysmal vascular diseases

52 predictive factors for cardiovascular diseases in women from the city of jataí, goiás states

53 stem cell-derived exosome in cardiovascular diseases: macro roles of micro particles

54 asymptomatic carotid artery stenosis in patients with severe peripheral vascular diseases

55 salusins: potential use as a biomarker for atherosclerotic cardiovascular diseases

56 guidelines on diabetes, pre-diabetes, and cardiovascular diseases

57 beneficial effects of whey protein preloads on some cardiovascular diseases risk factors of overweight and obese men are stronger than soy protein preloads – a randomized clinical trial

58 the use of calcium channel blockers in the treatment of cardiovascular diseases

59 periodontitis and cardiovascular diseases: the link and relevant mechanisms

60 the importance of selected spices in cardiovascular diseases

61 the prevalence and awareness of cardiovascular diseases risk factors among the lebanese population: a prospective study comparing urban to rural populations

62 emerging risk biomarkers in cardiovascular diseases and disorders

63 correlation between anthropometric indexes and risk factors of cardiovascular diseases among the elderly population in amirkola

64 effect of different glucose blood levels on the development of cardiovascular diseases and complications

65 dexamethasone- cyclophosphamide pulse in collagen vascular diseases: an observation

66 the current state of cell therapies for cerebrovascular diseases

67 microrna-143/-145 in cardiovascular diseases

68 avaliação da agregação plaquetária e dosagem do fibrinogênio em pacientes com doenças cardiovasculares e sua correlação com o uso de aspirina e fatores de risco coronariano evaluation of platelet aggregation and level of fibrinogen in patients with cardiovascular diseases and the correlation of taking aspirin with coronary risk factors

69 health innovation in cardiovascular diseases

70 the porphyromonas gingivalis/host interactome shows enrichment in gwasdb genes related to alzheimer's disease, diabetes and cardiovascular diseases

71 cardiovascular diseases in china: current status and future perspectives

72 effect of the amount and type of dietary fat on cardiometabolic risk factors and risk of developing type 2 diabetes, cardiovascular diseases, and cancer: a systematic review

73 incidence of cancers in patients with atherosclerotic cardiovascular diseases

74 molecular mechanisms explaining the possible effects of phenolic compounds on reducing the risk of cardiovascular diseases

75 the utilization of nonprescription medications in saudi patients with cardiovascular diseases

76 functional foods and nutraceuticals in the primary prevention of cardiovascular diseases

77 a 12- week water aerobic exercise and atorvastatin effect on changes of atrial natriuretic peptide and brain natriuretic peptide in older men with cardiovascular diseases

78 survey of network-based approaches to research of cardiovascular diseases

79 quantitative physiological measurements to evaluate the response of antivascular endothelial growth factor treatment in patients with neovascular diseases

80 oxidative stress in cardiovascular diseases and obesity: role of p66shc and protein kinase c

81 role of membrane lipids in the regulation of erythrocytic oxygen-transport function in cardiovascular diseases

82 streptococcus mutans and cardiovascular diseases

83 use of n-3 polyunsaturated fatty acids 90% (omacor) for therapy and prevention of cardio-vascular diseases

84 sex differences in the effect of type 2 diabetes on major cardiovascular diseases: results from a population-based study in italy

85 cardiovascular diseases: profile of male workers from a distillery in the countryside of sÃo paulo state

86 school of health for patients with cardio-vascular diseases: balance between andragogic and pedagogic educational models

87 diverse roles of macrophages in intraocular neovascular diseases: a review

88 dietary patterns, involvement in physical activity and body mass index of romanian adults having cardio-vascular diseases

89 suggested indications of clinical practice guideline for stem cell-therapy in cardiovascular diseases: a stepwise appropriate use criteria for regeneration therapy

90 if channel as an emerging therapeutic target for cardiovascular diseases: a review of current evidence and controversies

91 identify potential drugs for cardiovascular diseases caused by stress-induced genes in vascular smooth muscle cells

92 computational and mathematical methods in cardiovascular diseases

93 Sexual dimorphism in body fat distribution and risk for cardiovascular diseases

94 Socioeconomic status and trends in risk factors for cardiovascular diseases in the Danish MONICA population, 1982-1992

95 Exosome-Derived Mediators as Potential Biomarkers for Cardiovascular Diseases: A Network Approach

96 Prognostic significance of modern markers of severity and development of complications in acute cerebrovascular diseases

Keyword Connections

Journals

Research Groups

Bibliographies